Table 4.
Number of events: median (interquartile range Q1–Q3) | hbPA+ group, n = 31 | Control group, n = 27 | BF group, n = 18 | p value* |
GI at 12 weeks | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.46 |
RTI at 12 weeks | 0 (0–1) | 1 (0–2) | 0 (0–0.75) | 0.18 |
TI at 12 weeks | 0 (0–2) | 1 (0–2.5) | 0 (0–1) | 0.14 |
hbPA+ group, n = 22 | Control group, n = 19 | BF group, n = 18 | ||
GI at 1 year | 0 (0–1) | 0 (0–1) | 0 (0–0) | 0.75 |
RTI at 1 year | 3 (1.25–4) | 2 (1–5) | 2 (1–3) | 0.65 |
TI at 1 year | 3 (1.25–4) | 2 (1–5.5) | 2 (1–3.75) | 0.63 |
*No statistically significant difference in the number of infections (medians) among feeding groups was found (Kruskal-Wallis ANOVA with correction for ties)
GI gastrointestinal infections, RTI respiratory tract infection, TI total (respiratory and gastrointestinal) infection, hbPA+ group group receiving formula with high beta-PA concentration and GOS supplement, control group standard formula group, BF group breast-fed group